These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38369641)

  • 1. Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis.
    Olivero G; Taddeucci A; Vallarino G; Trebesova H; Roggeri A; Gagliani MC; Cortese K; Grilli M; Pittaluga A
    Br J Pharmacol; 2024 Jun; 181(12):1812-1828. PubMed ID: 38369641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody/receptor protein immunocomplex in human and mouse cortical nerve endings amplifies complement-induced glutamate release.
    Merega E; Prisco SD; Severi P; Kalfas F; Pittaluga A
    Neurosci Lett; 2015 Jul; 600():50-5. PubMed ID: 26049008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice.
    Di Prisco S; Merega E; Milanese M; Summa M; Casazza S; Raffaghello L; Pistoia V; Uccelli A; Pittaluga A
    Neuropharmacology; 2013 Dec; 75():337-46. PubMed ID: 23958452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis.
    Marte A; Cavallero A; Morando S; Uccelli A; Raiteri M; Fedele E
    J Neurochem; 2010 Oct; 115(2):343-52. PubMed ID: 20649849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental training is beneficial to clinical symptoms and cortical presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis.
    Bonfiglio T; Olivero G; Vergassola M; Di Cesare Mannelli L; Pacini A; Iannuzzi F; Summa M; Bertorelli R; Feligioni M; Ghelardini C; Pittaluga A
    Neuropharmacology; 2019 Feb; 145(Pt A):75-86. PubMed ID: 29402503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement selectively elicits glutamate release from nerve endings in different regions of mammal central nervous system.
    Merega E; Di Prisco S; Lanfranco M; Severi P; Pittaluga A
    J Neurochem; 2014 May; 129(3):473-83. PubMed ID: 24387009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the GABAergic system on the glutamate release of frontal cortex synaptosomes from Wistar rats with experimental autoimmune encephalomyelitis.
    Cid MP; Vilcaes AA; Rupil LL; Salvatierra NA; Roth GA
    Neuroscience; 2011 Aug; 189():337-44. PubMed ID: 21635939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in glutamate transport and group I metabotropic glutamate receptors in the rat brain during acute phase of experimental autoimmune encephalomyelitis.
    Sulkowski G; Dabrowska-Bouta B; Kwiatkowska-Patzer B; Struzyńska L
    Folia Neuropathol; 2009; 47(4):329-37. PubMed ID: 20054785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain.
    Sulkowski G; Dąbrowska-Bouta B; Salińska E; Strużyńska L
    PLoS One; 2014; 9(11):e113954. PubMed ID: 25426719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.
    Suchak SK; Baloyianni NV; Perkinton MS; Williams RJ; Meldrum BS; Rattray M
    J Neurochem; 2003 Feb; 84(3):522-32. PubMed ID: 12558972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies Against the NH
    Cisani F; Olivero G; Usai C; Van Camp G; Maccari S; Morley-Fletcher S; Pittaluga AM
    Front Immunol; 2021; 12():586521. PubMed ID: 33717067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis.
    Fernández Hurst N; Chanaday NL; Roth GA
    Inflamm Allergy Drug Targets; 2015; 14(2):105-10. PubMed ID: 26631092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
    Bourel J; Planche V; Dubourdieu N; Oliveira A; Séré A; Ducourneau EG; Tible M; Maitre M; Lesté-Lasserre T; Nadjar A; Desmedt A; Ciofi P; Oliet SH; Panatier A; Tourdias T
    Neurobiol Dis; 2021 Dec; 160():105533. PubMed ID: 34673149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice.
    Liu Y; Ding XF; Wang XX; Zou XJ; Li XJ; Liu YY; Li J; Qian XY; Chen JX
    BMC Complement Altern Med; 2019 Aug; 19(1):215. PubMed ID: 31412844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.
    Michailidou I; Willems JG; Kooi EJ; van Eden C; Gold SM; Geurts JJ; Baas F; Huitinga I; Ramaglia V
    Ann Neurol; 2015 Jun; 77(6):1007-26. PubMed ID: 25727254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation.
    Gharagozloo M; Smith MD; Jin J; Garton T; Taylor M; Chao A; Meyers K; Kornberg MD; Zack DJ; Ohayon J; Calabresi BA; Reich DS; Eberhart CG; Pardo CA; Kemper C; Whartenby KA; Calabresi PA
    Acta Neuropathol; 2021 Nov; 142(5):899-915. PubMed ID: 34487221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes.
    Bonanno G; Raiteri L; Milanese M; Zappettini S; Melloni E; Pedrazzi M; Passalacqua M; Tacchetti C; Usai C; Sparatore B
    Int Rev Neurobiol; 2007; 82():73-93. PubMed ID: 17678956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes.
    Lau CL; O'Shea RD; Broberg BV; Bischof L; Beart PM
    Br J Pharmacol; 2011 Jun; 163(3):533-45. PubMed ID: 21309758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.
    Gentile A; Musella A; De Vito F; Fresegna D; Bullitta S; Rizzo FR; Centonze D; Mandolesi G
    J Neuroinflammation; 2018 Jan; 15(1):5. PubMed ID: 29304807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.